Is this you? Create Your Porfile
Avatar

Dania Reiche

Solvay

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Dania Reiche is active.

Explore More

Publication

Featured researches published by Dania Reiche.

Archive | 2007

Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators

Jochen Antel; Peter-Colin Gregory; Josephus H. M. Lange; Michael Firnges; Dania Reiche

Archive | 2004

HYDRONOPOL DERIVATIVES AS AGONISTS ON HUMAN ORL1 RECEPTORS

Matthias Mentzel; Dania Reiche; Reinhard Brückner; Samuel David; Bartholomeus J. Van Steen; Uwe Schön; Daniel Jasserand; Ulf Preuschoff

Archive | 2007

Use of CBx cannabinoid receptor modulators as potassium channel modulators

Jochen Antel; Peter-Colin Gregory; Josephus H. M. Lange; Michael Firnges; Dania Reiche

Archive | 2006

Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions

Jochen Antel; Uwe Schoen; Harald Waldeck; Michael Wurl; Michael Firnges; Dania Reiche; Peter-Colin Gregory

Archive | 2006

Method of using potassium channel inhibiting compounds

Jochen Antel; Peter-Colin Gregory; Michael Firnges; Dania Reiche

Archive | 2006

N-Sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions

Jochen Antel; Michael Firnges; Uwe Schoen; Harald Waldeck; Michael Wurl; Dania Reiche; Peter-Colin Gregory

Archive | 2006

N-sulfamoyl-N'-benzopyranpiperidine compounds and uses thereof

Jochen Antel; Harald Waldeck; Uwe Schoen; Peter-Colin Gregory; Michael Wurl; Michael Firnges; Dania Reiche; Uwe Reinecker; Holger Sann

Archive | 2005

Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions

Jochen Antel; Peter-Colin Gregory; Uwe Reinecker; Michael Wurl; Uwe Schoen; Harald Waldeck; Michael Firnges; Dania Reiche

Archive | 2002

New 1-(1-(Hetero)aryl-1-perhydroxyalkylmethyl)-Piperazine derivatives, process for their preparation and pharmaceutical compositions containing the same

Jochen Antel; Reinhard Brückner; Samuel David; Christian Eeckhout; Daniel Jasserand; Ulf Preuschoff; Dania Reiche; Holger Sann

Archive | 2007

Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation

Daniel Jasserand; Matthias Mentzel; Janis Jaunzems; Werner Benson; Uwe Schön; Pieter Smid; Ulf Preuschoff; Michael Firnges; Holger Sann; Reinhard Brueckner; Martinus Adolfs; Amos Attali; Dania Reiche; Andrew C. McCreary

Explore More

Collaboration

Dive into the Dania Reiche's collaboration.

Top Co-Authors
Avatar

Jochen Antel

University of Duisburg-Essen

View shared research outputs
Top Co-Authors
Avatar

Michael Firnges

Solvay

View shared research outputs
Top Co-Authors
Avatar

Peter-Colin Gregory

Solvay

View shared research outputs
Top Co-Authors
Avatar

Uwe Schoen

Solvay

View shared research outputs
Top Co-Authors
Avatar

Harald Waldeck

Solvay

View shared research outputs
Top Co-Authors
Avatar

Holger Sann

Solvay

View shared research outputs
Top Co-Authors
Avatar

Michael Wurl

Solvay

View shared research outputs
Top Co-Authors
Avatar

Daniel Jasserand

Solvay

View shared research outputs
Top Co-Authors
Avatar

Ulf Preuschoff

Solvay

View shared research outputs
Top Co-Authors
Avatar

Uwe Reinecker

Solvay

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge